Table 2.
Study characteristics of specific group, (varicella seropositivity prevalence in Iranian areas between 2002 and 2012 by regions)
| Study’s First Author (year of collection*) | City | Target population | Prevalence of seropositivity in age groups [positive seroprevalence/ sample size (%)] | Reference | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16- 20 | 21- 25 | 26- 30 | 31- 35 | 36- 40 | 41-45 | 46-50 | 51-55 | 56-70 | ≥ 70 | Total | ||||
| Talebi-Taher (2009) | Tehran | Health care workers | 95/136 (69.8) | 74/103 (71.8) | 40/58 (68.9) | 39/55 (71.0) | 41/53 (77.4) | 289/405 (71.4) | 9 | |||||
| Talebi-Taher (2010) | Tehran | Patients on Hemodialysis | 24/27 (88.8) | 57/58 (98.2) | 53/53 (100) | 48/48 (100) | 183/187 (97.9) | 12 | ||||||
| Bayani (2011-2012) | Babol | Healthcare workers | 146/160 (91.2) | 240/248 (96.8) | 48/51 (94.1) | 434/459 (94.6) | 15 | |||||||
| Farshchi (2012) | Kermanshah | Health care workers | 10/16 (62.5) | 30/39 (76.9) | 80/88 (90.9) | 39/45 (86.7) | 159/188 (84.5) | 26 | ||||||